| Literature DB >> 32365625 |
Mónica V Cunha1,2,3, Teresa Albuquerque1, Patrícia Themudo1, Carlos Fonseca4, Victor Bandeira4, Luís M Rosalino2,4.
Abstract
The Egyptian mongoose is a carnivore mammal species that in the last decades experienced a tremendous expansion in Iberia, particularly in Portugal, mainly due to its remarkable ecological plasticity in response to land-use changes. However, this species may have a disruptive role on native communities in areas where it has recently arrived due to predation and the potential introduction of novel pathogens. We report reference information on the cultivable gut microbial landscape of widely distributed Egyptian mongoose populations (Herpestes ichneumon, n = 53) and related antimicrobial tolerance across environmental gradients. The panel of isolated species is consistent with the typical protein-based diet of a carnivore: Firmicutes predominate (89% of individuals), while Clostridiales, Enterobacteriales, and Lactobacillales are the major classes. Forty-one individuals (77.4%) harbour Clostridium spp. A spatial influence on mongooses' microbiota is confirmed by nonmetric multidimensional scaling analysis, with a significant contribution of municipality to their microbiota composition. Antimicrobial susceptibility testing of mongoose commensal bacteria to 28 compounds evidences xenobiotic tolerance of Escherichia coli (E. coli), enterococci, Salmonella Spartel and Mbandaka serotypes and Pseudomonas bacteria, among others. The common isolation of antimicrobial tolerant microbiota from the mongoose's gut suggests this species is exposed to anthropogenic influence and is affected by forestry and agricultural-related practices, reflecting its easy adaptation to ecological gradients across agroecosystems. We thus propose regular microbial and phenotypic resistance profiling of widely distributed mongooses as a sentinel tool for xenobiotics' lifecycle and ecosystem health in Portugal.Entities:
Keywords: Egyptian mongoose; Herpestes ichneumon; antimicrobial tolerance; carnivores; ecosystem health; gut microbiota; human health; wildlife management
Year: 2020 PMID: 32365625 PMCID: PMC7246908 DOI: 10.3390/ijerph17093104
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Geographical distribution and sampling range of 53 mongoose specimens. The location of specimens is represented in the map by grey circles. Thirty-five municipalities were sampled. The number of samples with the same GPS coordinates (latitude; longitude) is indicated according to circle diameter, as shown in legend. Black circles represent the specimens located within 15 km of priority intervention areas of the Iberian lynx Action Plan (dark grey areas). Figure produced with open-access software QGIS.
Mean resistance of isolates within each bacterial species to 28 antimicrobials. The number of isolates tested per species is indicated in brackets. Amoxicillin–clavulanic acid (AMC), Amoxicillin (AMO), Apramycin (APR), Cefoperazone (CFP), Cephalothin (CFT), Colistin (COL), Chloramphenicol (CMP), Doxycycline (DOT), Erythromycin (ERY), Enrofloxacin (ENR), Flumequin (FLU), Fusidic acid (FUC), Nitrofurantoin (FUR), Gentamicin (GEN), Kanamycin (KAN), Lincomycin (LIN), Metronidazol (MTR), Oxacillin (OXA), Oxolinic Acid (OXO), Penicillin (PEN), Pristinamycin (PRI), Rifampicin (RFA), Spectinomycin (SPE), Streptomycin (STR), Sulfamethizole (SUL), Tetracycline (TET), Cotrimoxazole (TSU), Tylosin (TYL).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 100 | 100 | 100 | 100 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 0 | 100 | 0 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 100 | 50 | 50 | 50 | 50 | 0 | 100 | 50 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 100 | 100 | |
|
| 100 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | |
|
| 100 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | |
|
| 43 | 0 | 0 | 0 | 29 | 0 | 100 | 71 | 100 | 100 | 100 | 0 | 29 | 0 | |
|
| 88 | 0 | 0 | 75 | 0 | 0 | 100 | 96 | 100 | 100 | 92 | 75 | 79 | 0 | |
|
| 100 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | |
|
| 100 | 100 | 100 | 100 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 0 | 100 | 0 | |
|
| 100 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | |
|
| 100 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | |
|
| 100 | 25 | 25 | 100 | 75 | 75 | 100 | 75 | 100 | 75 | 75 | 75 | 25 | 0 | |
|
| 100 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 100 | 100 | |
|
| 100 | 100 | 100 | 100 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 0 | 100 | 0 | |
|
| 0 | 0 | 0 | 100 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
|
| 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
| 100 | 43 | 0 | 100 | 100 | 0 | 57 | 0 | 57 | 57 | 57 | 57 | 0 | 0 | |
|
| 100 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 83 | 0 | 0 | |
|
| 100 | 100 | 100 | 100 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 0 | 100 | 0 | 0 | 100 | 0 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | |
|
| 0 | 100 | 0 | 0 | 100 | 100 | 100 | 50 | 50 | 50 | 0 | 100 | 0 | 100 | |
|
| 0 | 100 | 100 | 100 | 100 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
|
| 0 | 100 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | |
|
| 100 | 100 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 100 | 100 | |
|
| 57 | 43 | 0 | 0 | 100 | 14 | 14 | 43 | 43 | 100 | 0 | 0 | 0 | 0 | |
|
| 0 | 96 | 0 | 0 | 100 | 83 | 88 | 100 | 100 | 100 | 0 | 75 | 0 | 79 | |
|
| 100 | 100 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
| 0 | 100 | 0 | 0 | 100 | 0 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | |
|
| 0 | 0 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | |
|
| 100 | 100 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 100 | |
|
| 75 | 100 | 75 | 75 | 100 | 75 | 100 | 100 | 100 | 100 | 75 | 0 | 50 | 100 | |
|
| 100 | 100 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 25 | 0 | 100 | 100 | |
|
| 0 | 100 | 0 | 0 | 100 | 0 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | |
|
| 0 | 100 | 0 | 0 | 100 | 0 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | |
|
| 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 100 | |
|
| 100 | 100 | 100 | 100 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 100 | |
|
| 100 | 100 | 100 | 100 | 100 | 0 | 100 | 0 | 0 | 0 | 100 | 100 | 0 | 100 | |
|
| 100 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 0 | 100 | |
|
| 100 | 100 | 100 | 100 | 0 | 83 | 100 | 83 | 0 | 0 | 100 | 100 | 83 | 100 | |
|
| 100 | 100 | 100 | 100 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 100 | |
|
| 100 | 100 | 100 | 100 | 0 | 0 | 100 | 0 | 0 | 0 | 100 | 100 | 0 | 100 |
Figure 2Resistance of bacterial isolates to 28 antimicrobials. The bars represent the number of Gram-negative (in grey) and Gram-positive (in white) isolates exhibiting resistance to each antimicrobial, while the line represents the percentage of all resistant isolates. Legend: Amoxicillin–clavulanic acid (AMC), Amoxicillin (AMO), Apramycin (APR), Cefoperazone (CFP), Cephalothin (CFT), Colistin (COL), Chloramphenicol (CMP), Doxycycline (DOT), Erythromycin (ERY), Enrofloxacin (ENR), Flumequin (FLU), Fusidic acid (FUC), Nitrofurantoin (FUR), Gentamicin (GEN), Kanamycin (KAN), Lincomycin (LIN), Metronidazol (MTR), Oxacillin (OXA), Oxolinic Acid (OXO), Penicillin (PEN), Pristinamycin (PRI), Rifampicin (RFA), Spectinomycin (SPE), Streptomycin (STR), Sulfamethizole (SUL), Tetracycline (TET), Cotrimoxazole (TSU), Tylosin (TYL).
Figure 3Mean percentage of antimicrobial agents to which the isolates within each bacterial species are resistant. The white bars represent Gram-positive species while Gram-negative are presented in grey.